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Topoisomerase II is essential cellular enzyme, which modifies the secondary 
structure of DNA. By introducing a temporary double strand break to DNA it 
relieves a structural tension raised during transcription and translation. Absolutely 
indispensable is the role of topoisomerase II in the separation of sister chromatids 
synthesized in the S-phase of the cell cycle. The mechanism of DNA cleavage 
involves a covalent bond formed between active site tyrosine and 5‘ phosphate on 
both of the DNA strands and through the formed break the other strand or the other 
DNA molecule can pass. After that, the DNA strands are rejoined and topoisomerase 
II is detached.  
The indispensability of topoisomerase II mainly for proliferating cells makes it a 
great target for the antineoplastic drugs and the molecules belonging to the class of 
topoisomerase II inhibitors (etoposide, anthracyclines) are amongst the most useful 
anticancer drugs in the clinical practice. These clinically used „topoisomerase 
poisons“ act by stabilizing the covalent complex of topoisomerase II and the DNA 
and block the rejoining of the transient DNA break, which stops the cell cycle and 
can lead to permanent double strand breaks and DNA damage. Besides the intended 
antiproliferative effect, the DNA damage can also be a mechanism of toxicity of 
these drugs. 
In the Charles University Research Centre for the Study of Toxic and Protective 
Effects of Drugs on Cardiovascular System (UNCE 204019/304019/2012) the 
mechanisms of anthracycline cardiotoxicity are studied. Topoisomerase II inhibition 
is obviously the mechanism of anthracycline antineoplastic action, but recent 
investigations of this and other groups suggest, that it could be involved in the 
mechanisms of cardiotoxicity, which are still elusive. One of the approaches which 
could clarify this hypothesis could be the assessment of the level of topoisomerase II 
complexes with DNA formed upon the treatment of cardiomyocytes or cancer cells 
with anthracyclines and its comparison with the direct DNA damage measured using 
different method. 
The aim of this thesis was to optimize the method of detection of the 
topoisomerase II covalent complexes with DNA first in the HeLa cell line induced by 
etoposide and the comparison with direct assessment of the DNA damage by the 
Comet Assay. This optimization will enable further studies on different cell lines or 
the primary culture of isolated rat neonatal cardiomyocytes and using different 
topoisomerase II poisons (e.g. anthracyclines). 
